Literature DB >> 24778399

2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers.

Kathleen Lambein1, Mieke Van Bockstal2, Hannelore Denys2, Louis Libbrecht2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24778399     DOI： 10.1200/JCO.2013.54.2530

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Bilateral breast cancer with a unilateral carcinoma within a fibroadenoma: A case report.

Authors:  Hongmei Zheng; Jian Chen; Xinhong Wu; Liting Jin; Chubo Qi
Journal:  Oncol Lett       Date:  2015-06-24       Impact factor: 2.967

2.  Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Authors:  Kathleen Lambein; Mieke Van Bockstal; Lies Vandemaele; Rudy Van den Broecke; Veronique Cocquyt; Sofie Geenen; Hannelore Denys; Louis Libbrecht
Journal:  Virchows Arch       Date:  2017-05-31       Impact factor: 4.064

3.  New ASCO/CAP guideline recommendations for HER2 testing increase the proportion of reflex in situ hybridization tests and of HER2 positive breast cancers.

Authors:  N Tchrakian; L Flanagan; J Harford; J M Gannon; C M Quinn
Journal:  Virchows Arch       Date:  2015-10-31       Impact factor: 4.064

4.  Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.

Authors:  Mieke Van Bockstal; Kathleen Lambein; Hannelore Denys; Geert Braems; Ann Nuyts; Rudy Van den Broecke; Veronique Cocquyt; Olivier De Wever; Louis Libbrecht
Journal:  Virchows Arch       Date:  2014-06-29       Impact factor: 4.064

5.  Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis.

Authors:  Davide Ferraro; Jérôme Champ; Bruno Teste; Marco Serra; Laurent Malaquin; Jean-Louis Viovy; Patricia de Cremoux; Stephanie Descroix
Journal:  Sci Rep       Date:  2016-05-09       Impact factor: 4.379

6.  FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics.

Authors:  Stella Petroni; Lucia Caldarola; Rachele Scamarcio; Francesco Giotta; Agnese Latorre; Anita Mangia; Giovanni Simone
Journal:  Oncol Lett       Date:  2016-09-13       Impact factor: 2.967

7.  Breast carcinomas with low amplified/equivocal HER2 by Ish: potential supporting role of multiplex ligation-dependent probe amplification.

Authors:  Cristiana Ercolani; Caterina Marchiò; Anna Di Benedetto; Alessandra Fabi; Letizia Perracchio; Patrizia Vici; Francesca Sperati; Simonetta Buglioni; Vincenzo Arena; Edoardo Pescarmona; Anna Sapino; Irene Terrenato; Marcella Mottolese
Journal:  J Exp Clin Cancer Res       Date:  2017-10-13

8.  Hepatitis B virus infection specially increases risk of liver metastasis in breast cancer patients: a propensity-matched analysis.

Authors:  Ping Yu; Peng Liu; Na Li; Xinhua Xie; Hailin Tang; Jiali Wu; Yanan Kong; Xiaoming Xie; Feng Ye
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.